UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.94 Million Stake in Chimera Investment Corporation $CIM

Key Points

• UBS Asset Management significantly increased its Chimera Investment stake by 20,243.7% in the second quarter, holding 145,661 shares worth approximately $1.94 million. Institutional investors collectively own 48.44% of the REIT.
• Chimera Investment reported quarterly EPS of $0.46, below the $0.54 consensus estimate, while revenue of $94.77 million was also slightly below expectations.
• The stock opened at $11.13, near its 52-week low, and analysts maintain a consensus “Hold” rating with a $14.50 target price.

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Chimera Investment Corporation (NYSE:CIM - Free Report) by 20,243.7% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 145,661 shares of the real estate investment trust's stock after acquiring an additional 144,945 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.17% of Chimera Investment worth $1,943,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of CIM. Dynamic Technology Lab Private Ltd grew its holdings in Chimera Investment by 36.1% in the first quarter. Dynamic Technology Lab Private Ltd now owns 16,568 shares of the real estate investment trust's stock worth $213,000 after purchasing an additional 4,399 shares during the period. Empowered Funds LLC raised its holdings in shares of Chimera Investment by 12.9% during the first quarter. Empowered Funds LLC now owns 21,322 shares of the real estate investment trust's stock valued at $274,000 after purchasing an additional 2,430 shares during the period. Creative Planning raised its holdings in shares of Chimera Investment by 82.3% during the second quarter. Creative Planning now owns 21,766 shares of the real estate investment trust's stock valued at $302,000 after purchasing an additional 9,828 shares during the period. Cetera Investment Advisers boosted its position in shares of Chimera Investment by 6.1% during the 2nd quarter. Cetera Investment Advisers now owns 19,926 shares of the real estate investment trust's stock worth $276,000 after purchasing an additional 1,143 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its stake in shares of Chimera Investment by 42.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 246,471 shares of the real estate investment trust's stock valued at $3,419,000 after buying an additional 73,634 shares during the period. Institutional investors and hedge funds own 48.44% of the company's stock.

Chimera Investment Stock Down 0.4%

Chimera Investment stock opened at $11.13 on Friday. The firm has a market capitalization of $932.13 million, a price-to-earnings ratio of -10.92 and a beta of 1.66. The firm's fifty day moving average price is $12.14 and its two-hundred day moving average price is $12.90. Chimera Investment Corporation has a 1-year low of $11.06 and a 1-year high of $14.40. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 2.34.

Chimera Investment (NYSE:CIM - Get Free Report) last posted its earnings results on Wednesday, August 5th. The real estate investment trust reported $0.46 EPS for the quarter, missing the consensus estimate of $0.54 by ($0.08). Chimera Investment had a return on equity of 9.82% and a net margin of 0.14%.The business had revenue of $94.77 million for the quarter, compared to the consensus estimate of $95.30 million.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on CIM shares. Keefe, Bruyette & Woods decreased their target price on Chimera Investment from $15.00 to $14.00 and set a "market perform" rating for the company in a research report on Thursday, August 6th. Wall Street Zen upgraded Chimera Investment from a "sell" rating to a "hold" rating in a report on Sunday, June 28th. Royal Bank Of Canada reissued a "sector perform" rating and issued a $14.00 price objective on shares of Chimera Investment in a research note on Wednesday, June 3rd. Finally, Weiss Ratings upgraded Chimera Investment from a "sell (d)" rating to a "sell (d+)" rating in a report on Monday, August 17th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $14.50.

About Chimera Investment

Chimera Investment Corporation NYSE: CIM is a publicly traded real estate investment trust that specializes in investing in residential mortgage assets. The company's portfolio primarily consists of agency and non-agency residential mortgage-backed securities, whole loan residential mortgages and other mortgage-related assets. As a REIT, Chimera Investment aims to generate attractive risk-adjusted returns through its focus on high-quality collateral and disciplined risk management.

The firm's core business activities include identifying and acquiring portfolios of residential mortgage loans and securities from financial institutions and in the secondary market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.